It was not exactly a do-over, but a federal court did order the Food and Drug Administration to do additional analysis and reconsider its “no effect” determination from 2015 for the AquaBounty salmon.
The FDA has completed that work this week with the announcement of the availability of a draft
Continue Reading FDA releases draft amended environmental assessment for AquAdvantage salmon and sets virtual public meeting